Clinical trial
Efficacy of Retreatments With Intravitreal Bevacizumab
NCT00406744 · Asociación para Evitar la Ceguera en México, Other · Terminated
Key facts
| NCT number | NCT00406744 |
|---|---|
| Title | Efficacy of Retreatments With Intravitreal Bevacizumab |
| Official title | Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments |
| Lead sponsor | Asociación para Evitar la Ceguera en México, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Age Related Macular Degeneration, Choroidal Neovascularization |
| Intervention type | Drug |
| Interventions | Intravitreal injection of Bevacizumab |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 4, 2006 |
| Last update posted | Jun 3, 2024 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: